EGFR and non-small cell lung carcinoma: Forty mutated (Ex19del or L858R) and 21 EGFR wild-type blood samples of NSCLC patients were profiled by targeted bisulfite sequencing using a panel with 80,672 CpG sites, covering more than 1 million bases of the human genome.